|Articles|November 1, 2022

Veeva, Merck Sign Long-term Digital Strategy Agreement

Ten-year digital partnership aims to enhance patient experience

Veeva Systems, a cloud-based software provider for the life sciences industry, is forming a new 10-year strategic partnership agreement with Merck that builds on their existing 12-year partnership. Per the deal, Veeva will be providing Merck with a strategic pricing approach and Merck will have input into Veeva’s product roadmap.

According to the involved parties, the partnership helps accelerate Merck’s digital strategy and makes it more efficient for Merck to evaluate, purchase, operate, and create value from Veeva's products and services.

“Transforming our digital, data, and analytics capabilities is integral to enabling our global colleagues to deliver on our purpose of using the power of leading-edge science to save and improve lives around the world,” says Robert M. Davis, CEO and president, Merck. “Our strategic partnership with Veeva expands our capacity to leverage innovative technology and enhances our ability to deliver value to patients and all our stakeholders.”

Read more about the deal here.


Related to this article

Silver Spring, MD, USA - June 25, 2022: The FDA White Oak Campus, headquarters of the United States Food and Drug Administration, a federal agency of the Department of Health and Human Services (HHS). | © Tada Images - stock.adobe.com 521699065
In this week’s Pharma Pulse, the FDA launches a program that lets companies share its approval packages with foreign regulators, UPS agrees to acquire Australia and New Zealand health care courier Smartways Logistics and Cognizant introduces an AI-enabled patient hub offering.